More articles about: Diabetes

Research highlights alarming rates of diabetic retinopathy; an ophthalmologist shares what to know.

Although previously rare in young people with diabetes, an editorial in JAMA Ophthalmology notes that diabetic retinopathy is increasing in younger patients, urging clinicians to remain vigilant of symptoms.

GLP1RA drugs are used to treat obesity as well as type 2 diabetes. Research from University of Michigan Health finds that these drugs can also be effective in treating high iron levels, a cause and symptom of type 2 diabetes.

A study shows that disulfiram, known for causing severe hangover symptoms by blocking alcohol breakdown, also inhibits the inflammatory NLRP3 complex.

The idea of deprescribing is popular among older adults who take prescription drugs, especially those taking medication for symptomless conditions like high blood pressure.

Mohamed Noureldein, Ph.D., was named an inaugural Brehm-Concordia Scholar.

Women Inspiring and Elevating Leadership in Diabetes (WEILD) named Eva Feldman, M.D., Ph.D., as a woman shaping diabetes and metabolism research and care.

A national study from Michigan Medicine shows that the use of these weight loss drugs is increasing rapidly in adolescents and young adults 12-25 years, especially females.

A research team, led by Michigan Medicine and in partnership with Hurley Medical Center, finds that nearly three-quarters of patients at a clinic in Flint, Mich., a community that is predominantly Black and socioeconomically disadvantaged, had neuropathy — of which 75% was undiagnosed.

Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss.

U.S. News & World Report featured Drs. Evan Reynolds and Brian Callaghan, whose recent study found that total and out-of-pocket costs for diabetics run hundreds to thousands of dollars more than regular medical expenses for people without diabetes.

Dr. Evan Reynolds was interviewed by the public radio station about his recent findings that diabetes patients have higher costs out-of-pocket, a very problematic issue.

According to a Michigan Medicine study, people with diabetes, particularly those with type 1 diabetes, endure substantial out-of-pocket expenses compared to people without diabetes.

One diabetes program is moving to revolutionize investigations and treatment in the field

A large study shows having bipolar disorder is associated with a four- to six-fold risk of dying prematurely, suggesting more preventive efforts needed. Visit Health Lab to read the full story.